Clinical Trials
19 trialsNCT03093116 2026-05-27
TRIDENT-1
Turning Point Therapeutics, Inc.
Phase 1/2 Recruiting
NCT07377487 2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA Recruiting
NCT06881992 2026-05-18
Tumor HI
Rezolute
Phase 3 Recruiting
NCT02402244 2026-05-05
Project: Every Child for Younger Patients With Cancer
Children's Oncology Group
Recruiting
NCT06910657 2026-03-02
IDOV-Immune for Advanced Solid Tumors
ViroMissile, Inc.
Phase 1 Recruiting
NCT07412782 2026-02-17
REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
Meyer Children's Hospital IRCCS
Phase NA Recruiting
NCT07404176 2026-02-11
TENET
Tata Memorial Hospital
Phase 2 Recruiting
NCT07389512 2026-02-05
PharmTRT
Hospices Civils de Lyon
Recruiting
NCT06333314 2025-12-02
Pan-MSI-ACSE
UNICANCER
Phase 2 Recruiting
NCT05768178 2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT05024929 2025-11-14
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Children's Hospital of Philadelphia
Recruiting
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT06577987 2025-09-15
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Circle Pharma
Phase 1 Recruiting
NCT06908629 2025-08-26
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
Barbara Ann Karmanos Cancer Institute
Phase NA Recruiting
NCT04837885 2025-07-23
LUTARTERIAL
University Hospital, Bordeaux
Phase 2 Recruiting
NCT05944237 2025-06-08
HTL0039732 in Participants With Advanced Solid Tumours
Cancer Research UK
Phase 1/2 Recruiting
NCT06981455 2025-05-20
LIFENETS
Sunnybrook Health Sciences Centre
Recruiting
NCT06725693 2025-02-11
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
Tianjin Medical University
Recruiting
NCT04949282 2022-12-23
SEPTRALU
Sociedad Española de Medicina Nuclear e Imagen Molecular
Recruiting